If you're researching TRT or HRT in Florida, you're probably not looking for hype - you're looking for clarity.
Most patients want straightforward answers to real questions: Does this actually work? Is it safe? What does it cost month to month?
Those are exactly the right questions to ask.
Testosterone plays an important role in both men and women, influencing energy, mood, mental clarity, muscle and bone health, libido, sleep quality, and motivation. While testosterone replacement therapy (TRT) is most often discussed for men, testosterone can also be used carefully as part of hormone replacement therapy (HRT) for women at much lower doses and with close medical supervision.
At Thrive RX, one of the most common questions we hear from patients across Florida is: "What's the best way to take testosterone - injections, gels, pellets, or this new pill I keep hearing about?"
The honest answer is simple: There is no single best method for everyone.
The right option depends on effectiveness, safety, cost, convenience, and - most importantly - how easily the dose can be adjusted over time.
What Is Oral Testosterone (Kyzatrex)?
Kyzatrex is an FDA-approved oral capsule of testosterone undecanoate (TU) used for testosterone replacement in appropriate men with confirmed hypogonadism. It was approved by the U.S. Food and Drug Administration in July 2022.
Older oral testosterone formulations developed a poor reputation because they were associated with liver toxicity. Kyzatrex was designed to avoid this issue by using a different absorption pathway - through the lymphatic system rather than directly through the liver.
Because it is taken by mouth, Kyzatrex has generated interest as a non-injectable option that also avoids the skin-transfer risks associated with topical gels.
Interested in whether Kyzatrex could be a fit for you? Visit our Kyzatrex treatment page for candidacy criteria, safety monitoring, and pricing.
Does Oral Testosterone (Kyzatrex) Actually Work?
Yes - for appropriately selected patients, it can.
Clinical trials have shown that oral testosterone undecanoate can restore testosterone levels into the normal range in men with confirmed testosterone deficiency. In the Phase 3 clinical trial (MRS-TU-2019EXT), 88% of patients achieved normal testosterone levels (222-800 ng/dL) within 90 days, with up to 96% reaching target levels by six months.
Importantly, when TRT is prescribed and monitored correctly, symptom improvement is often similar across delivery methods.
A key takeaway for patients: When testosterone is dosed appropriately and monitored carefully, how you feel often matters more than how the medication gets into your body.
Where delivery methods differ most is in risk profile, cost, convenience, and dose flexibility.
Safety: What Patients Should Know About Kyzatrex
Blood pressure is the key safety consideration. Kyzatrex carries a boxed warning related to blood pressure increases because sustained elevations in blood pressure can increase cardiovascular risk in susceptible individuals.
Studies using ambulatory blood pressure monitoring have shown small but consistent increases in blood pressure in some patients taking oral testosterone undecanoate. The Phase 3 trial reported a mean systolic blood pressure increase of 1.7 mmHg.
What this means in real life:
- Kyzatrex may be reasonable for some patients
- It requires thoughtful patient selection
- It requires ongoing blood pressure monitoring, especially if you already have hypertension or cardiovascular risk factors
This doesn't mean Kyzatrex is unsafe - but it does require closer cardiovascular awareness compared to some other TRT options.
Standard TRT Monitoring Still Applies
Regardless of how testosterone is delivered, responsible TRT includes monitoring:
- Symptoms and quality of life
- Testosterone levels
- Hematocrit (red blood cell count)
- Blood pressure
- Prostate-related markers (in men, when appropriate)
This kind of structured, longitudinal monitoring is a core part of care at Thrive RX and is far more important than the delivery method itself.
Convenience: The Detail Most People Miss
Because Kyzatrex is a pill, many patients assume it must be the easiest option. But there are important practical details.
Kyzatrex is not a "take it whenever" medication. It is typically taken twice daily with meals, because food significantly affects absorption. Missed meals or inconsistent timing can affect testosterone levels and symptom control.
For some patients, this still feels easier than injections. For others, twice-daily dosing with food is actually less convenient than a weekly injection or a longer-acting option.
The Biggest Real-World Limitation: Cost
For many patients searching for TRT in Florida, cost becomes the deciding factor.
Even with discount programs, Kyzatrex is typically significantly more expensive than other testosterone options. Over time, that difference adds up - especially for long-term therapy.
| TRT Method | Typical Cost | Dosing Frequency | Key Considerations |
|---|---|---|---|
| Injectable testosterone (cypionate/enanthate) | $20-$100/month | Weekly or bi-weekly | Most affordable, highly adjustable |
| Topical gels/creams | $40-$100+/month | Daily | Variable absorption, transfer risk |
| Testosterone pellets | $400-$1,000 per insertion | Every 3-6 months | No dose adjustment once placed |
| Oral testosterone (Kyzatrex) | $400-$1,100/month | Twice daily with meals | Highest cost, BP monitoring required |
Bottom line: Even when Kyzatrex works well, it is often the least cost-effective option for long-term TRT.
How Kyzatrex Fits Among Other TRT Options
Understanding Kyzatrex is easier when it's viewed in context with other available testosterone delivery methods.
Injectable Testosterone: Most Common and Often the Best Starting Point
Injectable testosterone (most commonly cypionate or enanthate) remains the most widely used form of TRT - and for good reason.
- Highly effective and predictable
- Easy to adjust based on labs and symptoms
- Extremely cost-effective
- Supported by decades of clinical experience
The main drawback is the need for injections. When dosing is not properly tailored, some patients may experience fluctuations in hormone levels. However, this reflects suboptimal dosing strategy - not a limitation of injectable therapy itself.
At Thrive RX, dosing is carefully individualized and physician-guided by Dr. Kiswani-Barley to ensure stable levels and consistent symptom control. From a practical standpoint, injections are often the best way to dial in the correct dose, especially early in treatment.
Topical Gels or Creams
Topical testosterone appeals to patients who want to avoid needles. They can work well, but tradeoffs include:
- Variable absorption between patients
- Daily application required
- Risk of transferring testosterone to partners or children
Testosterone Pellets: Popular, but Often Misunderstood
Pellets are heavily marketed in Florida as a "set it and forget it" option. While FDA-approved pellets exist for men, many pellet programs - especially those used for women - rely on compounded pellets, which are not FDA-approved and introduce additional variability.
The most important limitation is dose inflexibility. Once pellets are implanted:
- The dose cannot be adjusted
- If levels overshoot, they cannot be "turned down"
- Side effects may persist for weeks or months
- Minor procedural risks exist (infection, extrusion, scarring)
Clinical takeaway: Pellets may make sense after a stable dose and response are established. They are often a poor first-line option when hormones are still being optimized, because adjustability matters.
Where Kyzatrex May - and May Not - Make Sense
Kyzatrex may be reasonable if you:
- Have confirmed hypogonadism with clear symptoms
- Strongly prefer oral therapy
- Have well-controlled blood pressure
- Can reliably take medication with meals
- Understand the cost and monitoring requirements
It is often not the best choice if you:
- Need an affordable long-term option
- Want maximum dose flexibility early on
- Have uncontrolled hypertension or significant cardiovascular risk
- Prefer the simplest possible routine
A Note on Women, Testosterone, and HRT
Testosterone is not exclusively a male hormone. In women, it can support:
- Energy and motivation
- Sexual desire and responsiveness
- Lean muscle and bone health
- Mood and cognitive function
In women, doses are much lower, and small adjustments can have a big impact. For this reason, delivery methods that allow precise titration are often preferred during hormone optimization.
Testosterone is never used in isolation for women at Thrive RX and is always considered within a broader HRT framework.
The Most Important Decision: Choosing the Right Provider
The most important factor in TRT or HRT isn't the medication - it's the clinician guiding the therapy. Look for a provider who:
- Confirms the diagnosis properly
- Evaluates sleep, weight, medications, and metabolic health
- Monitors labs and symptoms systematically
- Understands cardiovascular and blood pressure risk
- Adjusts therapy thoughtfully over time
The Bottom Line
Kyzatrex (oral testosterone undecanoate) is a legitimate, FDA-approved option for testosterone replacement and can be effective in select patients.
However, for most patients, it is not the most practical first-line choice, primarily due to cost and limited advantages over established methods.
For many patients, injectable testosterone remains the most affordable, flexible, and effective way to optimize hormones, especially when guided by an experienced, physician-led practice.
The goal of hormone therapy isn't chasing the newest option. It's feeling like yourself again - safely, sustainably, and with expert guidance.
If you're exploring TRT or HRT in Florida and want a thoughtful, evidence-based approach, Thrive RX is here to help. Our board-certified physicians provide convenient telehealth appointments for patients throughout Florida.
References
- U.S. Food and Drug Administration. KYZATREX (testosterone undecanoate) Prescribing Information. FDA.gov; July 2022.
- Marius Pharmaceuticals. Phase 3 Clinical Trial (MRS-TU-2019EXT): A Phase III, Single-Arm, 6-Month Trial of Oral Testosterone Undecanoate. 2019-2020.
- Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2018;103(5):1715-1744.doi:10.1210/jc.2018-00229
- Swerdloff RS, et al. Treatment of Symptomatic Male Hypogonadism with New Oral Testosterone Therapies: A Comparative Review of Jatenzo, Tlando, and Kyzatrex. Medicines. 2025;13(1):1.doi:10.3390/medicines13010001
- American Urological Association. Evaluation and Management of Testosterone Deficiency: AUA Guideline. Journal of Urology. 2018;200(2):423-432.doi:10.1016/j.juro.2018.03.115
- Corona G, et al. Testosterone Supplementation and Cardiovascular Risk: A Meta-Analysis. European Journal of Endocrinology. 2022;187(4):505-516.doi:10.1530/EJE-22-0327